Another company has elected to add bitcoin (BTC) to its balance sheet.
Christian Angermayer, the chairman of Germany-based biopharmaceutical company atai Life Sciences (ATAI) announced today that the firm would develop its own bitcoin treasury strategy.
STORY CONTINUES BELOW
Don’t miss another story.Subscribe to the Crypto for Advisors Newsletter today. See all newsletters svg]:max-w-[theme(spacing.8)] transition-transform-colors-opacity motion-reduce:transition-none text-default-foreground data-[hover=true]:opacity-hover w-full md:w-auto bg-new-yellow”>
Sign me up
By signing up, you will receive emails about CoinDesk products and you agree to our terms of use and privacy policy.
“In an era of persistent inflation and volatile markets, I find myself asking an important question for biotech companies looking to preserve and optimize the capital they have: Could
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!